Dr Graff discusses the recommendations for identifying, evaluating, and managing neurological toxicities, including workup ...

For decades, the medical world has avidly searched for groundbreaking treatments against one of humanity’s most resilient ...

There's no place like home; it's where our pets find comfort, security, and safety. Some common household items, however, can ...

Dr Graff discusses how to operationalize bispecific antibody (BsAb) therapy in community practices by summarizing the ...

Failing to show a clinical benefit can mean several things: The trial did not achieve a statistically significant ...

LOUISVILLE, Ky. -- A CD70-targeted CAR T-cell therapy for advanced kidney cancer continued to show durable activity in ...

OCT for early diagnosis and characterization of dermatologic adverse events to oncologic drugs and correlation to ...

Typically, the problems that veterinarians see associated with the day are gastrointestinal issues as your dog is ...

Researchers say study offers proof-of-concept that targeting how T cells interact with metabolites in their environment can ...

Nectin-4 is a cell-adhesion molecule overexpressed in several tumor types, including breast, ovarian, lung, colorectal, pancreatic and urothelial cancer. Enfortumab vedotin (EV), an anti-Nectin-4 ...

The following is a summary of “Prevalence and outcomes of cancer and treatment-associated toxicities for patients with Ataxia Telangiectasia,” published in the November 2024 issue of Allergy and ...

Preliminary results from Phase 1 ACESOT-1051 trial of WEE1 inhibitor, APR-1051, demonstrate the product to be well-tolerated with no unexpected ...